Efficacy and Safety of Thermotherapy in Combination With Miltefosine Compared Iltefosine Monotherapy for the Treatment of New World Cutaneous Leishmaniasis: A Phase III, Open Label, Multicenter Randomized Trial
Latest Information Update: 26 Feb 2024
At a glance
- Drugs Miltefosine (Primary) ; Meglumine antimonate
- Indications Cutaneous leishmaniasis
- Focus Therapeutic Use
- 21 Feb 2024 Planned End Date changed from 17 Feb 2024 to 22 Feb 2024.
- 18 Sep 2023 Planned End Date changed from 30 Mar 2023 to 17 Feb 2024.
- 18 Sep 2023 Planned primary completion date changed from 30 Jun 2022 to 17 Nov 2023.